Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Segün Doğru, Ekrem Yaşar & Akın Yeşilkaya. (2022) Uric acid can enhance MAPK pathway-mediated proliferation in rat primary vascular smooth muscle cells via controlling of mitochondria and caspase-dependent cell death. Journal of Receptors and Signal Transduction 42:3, pages 293-301.
Read now
Read now
Shuo Zhang, Lin Liu, Yu-Qing Huang, Kenneth Lo, Songtao Tang & Ying-Qing Feng. (2020) The association between serum uric acid levels and ischemic stroke in essential hypertension patients. Postgraduate Medicine 132:6, pages 551-558.
Read now
Read now
Nurgül Oğuz, Mustafa Kırça, Arzu Çetin & Akın Yeşilkaya. (2017) Effect of uric acid on inflammatory COX-2 and ROS pathways in vascular smooth muscle cells. Journal of Receptors and Signal Transduction 37:5, pages 500-505.
Read now
Read now
Articles from other publishers (26)
Youqian Zhang, Zitian Tang, Ling Tong, Yang Wang & Lin Li. (2023) Serum uric acid and risk of diabetic neuropathy: a genetic correlation and mendelian randomization study. Frontiers in Endocrinology 14.
Crossref
Crossref
Alma Čypienė, Silvija Gimžauskaitė, Egidija Rinkūnienė, Eugenijus Jasiūnas, Aleksandras Laucevičius, Ligita Ryliškytė & Jolita Badarienė. (2023) Effect of Alcohol Consumption Habits on Early Arterial Aging in Subjects with Metabolic Syndrome and Elevated Serum Uric Acid. Nutrients 15:15, pages 3346.
Crossref
Crossref
Yong Zhuang, Huibin Huang, Xin Hu, Jinying Zhang & Qingyan Cai. (2022) Serum uric acid and diabetic peripheral neuropathy: a double-edged sword. Acta Neurologica Belgica 123:3, pages 857-863.
Crossref
Crossref
Kaiyue Li, Kongwei Li, Qingmei Yao, Xiaorong Shui, Jing Zheng, Yuan He & Wei Lei. (2023) The potential relationship of coronary artery disease and hyperuricemia: A cardiometabolic risk factor. Heliyon 9:5, pages e16097.
Crossref
Crossref
Mustafa KIRÇA. (2022) THE EFFECT OF ANGIOTENSIN II ON VASCULAR SMOOTH MUSCLE CELL PROLIFERATION IN HIGH GLUCOSE MEDIA. Kocatepe Tıp Dergisi 23:4, pages 399-405.
Crossref
Crossref
Sidar Copur, Atalay Demiray & Mehmet Kanbay. (2022) Uric acid in metabolic syndrome: Does uric acid have a definitive role?. European Journal of Internal Medicine 103, pages 4-12.
Crossref
Crossref
Zicen Fang, Zhenhui Luo, Yanying Ji, Rihong Yang, Jintian Gao & Nana Zhang. (2022) A network pharmacology technique used to investigate the potential mechanism of Ligustilide's effect on atherosclerosis. Journal of Food Biochemistry 46:7.
Crossref
Crossref
Amany A. Azouz, Hany A. Omar, Fatema Hersi, Fares E.M. Ali & Asmaa Mohammed M. Hussein Elkelawy. (2022) Impact of the ACE2 activator xanthenone on tacrolimus nephrotoxicity: Modulation of uric acid/ERK/p38 MAPK and Nrf2/SOD3/GCLC signaling pathways. Life Sciences 288, pages 120154.
Crossref
Crossref
Yoshitaka Kimura, Daisuke Tsukui & Hajime Kono. (2021) Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis. International Journal of Molecular Sciences 22:22, pages 12394.
Crossref
Crossref
Yousuf Waheed, Fan Yang & Dong Sun. (2021) Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease. The Korean Journal of Internal Medicine 36:6, pages 1281-1293.
Crossref
Crossref
Fei Liu, Simei Hui, Tesfaldet H. Hidru, Yinong Jiang, Ying Zhang, Yan Lu, Haichen Lv, Sharen Lee, Yunlong Xia & Xiaolei Yang. (2021) The Prevalence, Distribution, and Extent of Subclinical Atherosclerosis and Its Relation With Serum Uric Acid in Hypertension Population. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Shuai Huo, Hongxin Wang, Meixia Yan, Peng Xu, Tingting Song, Chuang Li, Ruimin Tian, Xiaoling Chen, Kun Bao, Ying Xie, Ping Xu, Weimin Zhu, Fengsong Liu, Wei Mao & Chen Shao. (2021) Urinary Proteomic Characteristics of Hyperuricemia and Their Possible Links with the Occurrence of Its Concomitant Diseases. ACS Omega 6:14, pages 9500-9508.
Crossref
Crossref
Rong Tang, Xiaoqing Peng, Yan Wang, Xiaohong Zhou & Hong Liu. (2021) Network Pharmacology-Based Investigation of the Mechanism of Action of Plantaginis Herba in Hyperuricemia Treatment. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-8.
Crossref
Crossref
Boyang Xiang, Xiaoya Zhao & Xiang Zhou. (2021) Cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors in diabetic and nondiabetic patients. Cardiovascular Diabetology 20:1.
Crossref
Crossref
Federica Piani, Arrigo F. G. Cicero & Claudio Borghi. (2021) Uric Acid and Hypertension: Prognostic Role and Guide for Treatment. Journal of Clinical Medicine 10:3, pages 448.
Crossref
Crossref
Michael Toprover, Binita Shah, Cheongeun Oh, Talia F. Igel, Aaron Garza Romero, Virginia C. Pike, Fatmira Curovic, Daisy Bang, Deana Lazaro, Svetlana Krasnokutsky, Stuart D. Katz & Michael H. Pillinger. (2020) Initiating guideline-concordant gout treatment improves arterial endothelial function and reduces intercritical inflammation: a prospective observational study. Arthritis Research & Therapy 22:1.
Crossref
Crossref
Nikolas Rapp, Pieter Evenepoel, Peter Stenvinkel & Leon Schurgers. (2020) Uremic Toxins and Vascular Calcification–Missing the Forest for All the Trees. Toxins 12:10, pages 624.
Crossref
Crossref
Pan Jing, Min Shi, Liang Ma & Ping Fu. (2020) Mechanistic Insights of Soluble Uric Acid-related Kidney Disease. Current Medicinal Chemistry 27:30, pages 5056-5066.
Crossref
Crossref
Fu-Shun Yen, Chih-Cheng Hsu, Hsin-Lun Li, James Cheng-Chung Wei & Chii-Min Hwu. (2020) Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout. Frontiers in Medicine 7.
Crossref
Crossref
Bingqing Zhang, Mengyuan Duan, Bo Long, Baozhong Zhang, Dongmei Wang, Yun Zhang, Jialin Chen, Xiaoming Huang, Yang Jiao, Lei Zhu & Xuejun Zeng. (2019) Urate transport capacity of glucose transporter 9 and urate transporter 1 in cartilage chondrocytes. Molecular Medicine Reports.
Crossref
Crossref
Shuangshuang Zhang, Yong Wang, Jinsong Cheng, Ning Huangfu, Ruochi Zhao, Zhenyu Xu, Fuxing Zhang, Wenyuan Zheng & Dandan Zhang. (2019) Hyperuricemia and Cardiovascular Disease. Current Pharmaceutical Design 25:6, pages 700-709.
Crossref
Crossref
Min Tao, Xiaoling Pi, Xiaoyan Ma, Yingfeng Shi, Yuzhen Zhang, Hongwei Gu, Yongbin Chi, Shougang Zhuang & Na Liu. (2019) Relationship between serum uric acid and clustering of cardiovascular disease risk factors and renal disorders among Shanghai population: a multicentre and cross-sectional study. BMJ Open 9:3, pages e025453.
Crossref
Crossref
Canan Topçuoğlu. (2018) Is There a Prognostic Significance of Serum Uric Acid Levels in Cardiac Dysfunction?. Ankara Medical Journal.
Crossref
Crossref
Xiaojie Zhang, Qing Lu, Zhuojun Zhang, Yongle Chen, Yanan Wang, Youngshi Wang, Zheng Li & Lindi Jiang. (2018) Value of three-dimensional speckle tracking echocardiography to assess left ventricular function in hyperuricemia patients. Clinical Rheumatology 37:9, pages 2539-2545.
Crossref
Crossref
Barbara Nieradko-Iwanicka. (2018) What is the role of angiotensin receptor blockers in treatment of hyperuricemia coexisting with arterial hypertension?. Rheumatology 56:2, pages 106-110.
Crossref
Crossref
Seong-Kyu Kim. (2018) Interrelationship of Uric Acid, Gout, and Metabolic Syndrome: Focus on Hypertension, Cardiovascular Disease, and Insulin Resistance. Journal of Rheumatic Diseases 25:1, pages 19.
Crossref
Crossref